Your first 90 days on a GLP-1
Week by week: what the starter dose actually feels like, when appetite changes show up, when your provider will titrate, and the three weeks most people find hardest.
Weight Loss · Tablet
Oral GLP-1
Daily GLP-1 tablets for patients who will not use injections. Lower average reduction than the weekly shot, but a plan you will actually follow beats one you abandon.
Pricing confirmed on your consultation
Your consult is free. We will not prescribe this — or anything — before a clinician has spoken with you and reviewed your bloodwork. Final cost depends on the form and dose prescribed.
Compounded · Rx only
Mechanism
Same pathway, different delivery.
Oral GLP-1 formulations deliver the same appetite-signalling mechanism as the injectable, absorbed through the stomach lining rather than subcutaneous tissue.
Absorption is more sensitive to timing. Tablets are taken on an empty stomach with a small sip of water, at least 30 minutes before food, drink or other medication.
Average weight reduction is lower than injectable therapy. For needle-averse patients, the adherence gain often outweighs the potency gap.
Protocol
How treatment usually runs.
A typical schedule. Yours is set by your clinician after your labs come back.
| Phase | Weeks | Typical | Purpose |
|---|---|---|---|
| Start | 1–4 | Lowest tablet strength | Tolerance and absorption habit. |
| Step up | 5–8 | Mid strength | First therapeutic level for most patients. |
| Maintenance | 9+ | Highest tolerated | Set by your provider based on response. |
What to expect
Honestly, over time.
Week 1–2
Building the habit
Timing matters more than dose early on. Nausea is usually mild.
Week 4–8
Appetite change
Fullness arrives earlier in meals.
Month 3–6
Steady progress
Slower than injectable, but consistent.
Month 12+
Reassess
Your provider may discuss switching to injectable if progress stalls.
Evidence
What the research shows.
Oral GLP-1 therapy produces meaningful but smaller average weight reduction than weekly injectable semaglutide or tirzepatide in published trials.
The trade-off is adherence. Patients who refuse injections often do better on a tablet they take than an injection they skip.
Safety and eligibility
Your consult and labs screen for all of the following.
- Do not take with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Do not take if pregnant or breastfeeding.
- Absorption is timing-dependent — taking it with food substantially reduces effectiveness.
- Common side effects include nausea, reflux and constipation.
FAQ
Oral GLP-1 questions.
Generally not for weight reduction — injectable formulations produce larger average loss. The tablet is a strong option for patients who will not use needles, where adherence often matters more than peak potency.
On an empty stomach, with no more than about four ounces of water, at least 30 minutes before eating, drinking anything else, or taking other medication. Taking it with food markedly reduces absorption.
Yes. Many patients start oral and move to injectable if progress stalls or they become comfortable with injections. Your provider manages the transition and starting dose.
We will not prescribe before we understand you.
Book a one-to-one consult with the clinical team. We talk through your goals, order the bloodwork that matters, and build a plan from what we find.